Combination of PD-L1 and CD8+ TILS in gastric cancer specimens is of great significance to evaluate the immune status and prognosis of gastric cancer [26], showing to be related to the low survival rate of esophageal cancer, gastric cancer, colorectal cancer, and lung cancer [27, 28]. This evidence concerns the gene CD8A and gastric cancer.